MyVitalC for Sleep and Headaches
What You Need to Know Before You Apply
What is the purpose of this trial?
Sleep disturbance and recurring headaches can negatively affect daily functioning, mood, and productivity. MyVitalC (ESS60 in extra virgin olive oil) is a commercially available dietary supplement that has generated anecdotal claims related to sleep quality and headache relief; however, human data remain limited.
This real-world observational study is designed to help participants evaluate whether use of MyVitalC is associated with changes in sleep disturbance and headache frequency or severity in their own daily lives. Participants will complete a four-week baseline observation period without the intervention, followed by six weeks of daily MyVitalC use, with weekly self-reported assessments. Participants serve as their own control, allowing for within-person comparison of outcomes before and during product use.
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Observation
Participants complete a four-week baseline observation period without the intervention, with weekly self-reported assessments
Treatment
Participants use MyVitalC daily for six weeks with weekly self-reported assessments
Follow-up
Participants are monitored for changes in sleep disturbance and headache frequency or severity after treatment
What Are the Treatments Tested in This Trial?
Interventions
- MyVitalC (ESS60 in Extra Virgin Olive Oil)
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Single Arm longitudinal where participants act as their own control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Efforia, Inc
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.